Scholars Central

OpinionPublished 30 Sep 2022

Gemcitabine Improves Survival and Clinical Benefits for Patients with Advanced Pancreatic Cancer

Authors: Charles Darwin

Journal of Cancer & Metastasis Research

Volume 5 · Issue 3 · Pages 66–67

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Only very lately has the idea of a chemotherapy-induced, palliative effect on disease-related symptoms in patients with pancreatic cancer been discussed in the literature. When attempting to evaluate whether treatment with various 5-FU-containing regimens led in an improvement in performance status, a weight gain, or an improvement in tumor-related symptoms in patients with gastric or pancreatic cancer, suggested that these criteria may be used to gauge the clinical effectiveness of a given therapy. Using that earlier work as a foundation and the aim to quantify any improvement in disease-related symptoms, we created the clinical benefit concept as a way to evaluate the impact of cancer chemotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer & Metastasis Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Charles Darwin”